Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11: early-phase trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11: 6 US clinical trials tracked, none currently recruiting.

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 5 of these trials.

Enrollment posture brief

Registry condition adult-acute-myeloid-leukemia-with-inv16p131q22-cbfb-myh11

OPEN 0 | RECR 0% | LATE 0 | EARLY 6 | RANK #2866 | SPON 5

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Adult Acute Myeloid Leuk (th…0%
Open-enrollment share among volume-matched conditions near Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 research.

    National Cancer Institute (NCI) accounts for 5 of 6 trials (83.3%). 2 distinct sponsors appear on at least one study for this condition label.

  3. Typical Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 enrolment sits around 133 participants.

    Median target enrolment is 133 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 24

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4

Top Sponsors

National Cancer Institute (NCI) 5 trials
Fred Hutchinson Cancer Center 1 trials

Named interventions

Most-linked intervention names on Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Laboratory Biomarker Analysis Other
3 trials
Daunorubicin Hydrochloride Drug
2 trials
Cytarabine Drug
2 trials
Azacitidine Drug
2 trials
Autologous Bone Marrow Transplantation Procedure
1 trials
Autologous Hematopoietic Stem Cell Transplantation Procedure
1 trials
Allogeneic Hematopoietic Stem Cell Transplantation Procedure
1 trials
Bortezomib Drug
1 trials

US sites by state

Facility locations filed on Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 trials. A trial with sites in several states counts in each.

Illinois 4 trials
Florida 3 trials
Wisconsin 2 trials
Indiana 2 trials
Georgia 2 trials
Delaware 2 trials
California 2 trials
Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • National Cancer Institute (NCI) sponsors the most Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 condition card totals 6 registered trials; most-linked intervention Laboratory Biomarker Analysis; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.